Media Thread, page-15786

You need to work on getting your facts correct

ALA - funded to phase 1 human trial data, cash not an issue. Haven't yet submitted IND application, still gathering the required information to be able to submit for approvals, and applying for entire platform designation at that.

Have you stopped to think, that maybe IMU didnt want to progress with the ALA trials because it was outperforming what IMU had already invested in?

Very soon, you will see studies where its confirmed iNKT cells have superior antitumor effects when compared to T-cell treatments.

Maybe its time to jump onboard instead of bagging them out every chance you get